Taking place on 5 July: New concepts in COPD

Taking place on 5 July, this ERS Vision Live panel discussion will focus on new concepts in chronic obstructive pulmonary disease (COPD).
The expert panellists will discuss key areas, including:
Pharmacological management of COPD
Role of eosinophils as biomarkers in COPD
Pre-COPD, PRISm and early/young COPD
This event is free to access but registration is required.
Chairs: Alvar Agustí, Marta Drummond.
Speakers: Speakers: Prof. Dave Singh, Prof. Dr Claus Vogelmeier, Dr MeiLan Han
Date: 5 July, 2023 | 18:00–19:00 CEST
Fuente de la información en este link, donde también puedes apuntarte: https://www.ersnet.org/events/new-concepts-in-copd/#ProfMartaDrummond
Noticias relacionadas

Human senescent fibroblasts trigger fibrogenic reaction in the lungs of immunodeficient mice
A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as «Aging (Albany NY)» and «Aging-US» by Web of Science) Volume 15, Issue 14, entitled, «Human senescent fibroblasts trigger progressive lung fibrosis in mice.»

COPD and multimorbidity: recognising and addressing a syndemic occurrence
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression
The role of the immune response in the pathogenesis of idiopathic pulmonary fibrosis (IPF) remains controversial.
Más artículos
Últimos artículos
- GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee
- Shyamali C Dharmage, et al. Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study.
- José Luis Izquierdo, José Miguel Rodríguez, Carlos Almonacid, María Benavent, Ramón Arroyo-Espliguero, Alvar Agustí – Real-life burden of hospitalisations due to COPD exacerbations in Spain
- Alvar Agustí, Eleni Rapsomaniki, Richard Beasley, Rod Hughes, Hana Müllerová, Alberto Papi,Ian D. Pavord, Maarten van den Berge, Rosa Faner – Treatable traits in the NOVELTY study1. 2022
- Agustí, A., et al., Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial. European Respiratory Journal, 2022. 59(3): p. 2103036
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida mediante capturas en el documento enlazado en la parte pública del artículo en (https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00302-2/fulltext) : https://www.healthdata.org/sites/default/files/files/policy_report/2019/GBD_2017_Booklet.pdf